Parkinson’s UK responds to the government’s consultation on the future of the NHS in England Date 10 December 2024
NHS Scotland rejects advanced Parkinson's treatment Date 10 December 2024 We're disappointed that Lecigon, a new treatment for advanced Parkinson's, has been rejected by NHS Scotland. We're increasingly concerned about access to advanced treatments in Scotland.
Parkinson’s UK responds to the government’s consultation on the future of the NHS in England Date 10 December 2024 The government asked what should be in its 10 Year Health Plan for England. The Parkinson's community has told them what needs to happen to improve healthcare.
First ever government forum to address gaps in neurological care launches Date 9 December 2024 Following the Neurological Alliance's #BackThe1in6 campaign, which Parkinson's UK supported, the UK government has launched the first ever forum to address gaps in treatment and care for people affected by neurological conditions.
Fixing the time critical medication problem in Scotland Date 28 November 2024 Earlier this week we brought together healthcare professionals, charities, people with Parkinson's and senior Scottish government officials for a summit in Edinburgh on time critical medication.
Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024 The TOP HAT trial was halted in April. We’re delighted to announce that it is restarting.
How does the new assisted dying bill affect people with Parkinson's? Date 20 November 2024 Our position on the legislation due for debate in the Westminster parliament, and answers to your key questions.
Parkinson’s UK awards £1m to new research projects Date 5 November 2024 Parkinson’s UK has granted funding to projects aiming to advance our understanding of the causes and symptoms of Parkinson’s, as well as exploring new treatments.
Autumn Budget 2024: What it means for people with Parkinson’s Date 1 November 2024 It was a Budget with big announcements on the NHS in England and social security and life sciences across the UK, but we await more details to understand whether it will truly deliver for the Parkinson’s community.
Parkinson's UK and England Boxing join forces to deliver new coaching programme Date 30 October 2024 Parkinson's UK and England Boxing have joined forces to help more coaches and instructors to deliver Parkinson's specific non-contact boxing sessions.
Results from the phase 3 trial of exenatide shared with participants Date 15 October 2024 The results indicate that people in the study who received exenatide did not benefit compared to those who received placebo - suggesting that the drug does not slow down the progression of Parkinson’s.